Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Stone

Showing results (461-470 of 544) with videos related to

Pageof 55
Sort By:
The Australian Journal of Rural Health|December 10, 2025
Emergency Department Fascia Iliaca Block Catheters: A Safe and Feasible Pathway to Hip Fracture AnalgesiaRuth Miriam Blank, Sebastiaan Paul Blank, Phuong Markman, et al.
American Journal of Hematology|October 29, 2010
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutationsHarshabad Singh, Lillian Werner, Daniel Deangelo, et al.
Oncotarget|January 5, 2018
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibitionEllen L Weisberg, Martin Sattler, Abdel Kareem Azab, et al.
Oncotarget|June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemiaAshujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemiaMitch Raponi, Jean-Luc Harousseau, Jeffrey E Lancet, et al.
Blood|November 15, 2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionCatia Fonseca, Robert Soiffer, Vincent Ho, et al.
Blood|November 28, 2013
MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cellsSuiyang Liu, Li Yin, Dina Stroopinsky, et al.
Leukemia & Lymphoma|October 15, 2016
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemiaJohn F Seymour, Hartmut Döhner, Mark D Minden, et al.
Bioengineering & Translational Medicine|September 11, 2023
Quatramer™ encapsulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancerSachchidanand Tiwari, Suiyang Liu, Mohd Anees, et al.
Emergency Medicine Australasia : EMA|October 13, 2021
Recent amendments to Queensland legislation make mental health presentations to hospital emergency departments more difficult to scrutiniseAlan R Clough, Angela Evans, Kristy Grant, et al.
Pageof 55

Showing results (461-470 of 544) with videos related to

Sort By:
Pageof 55
The Australian Journal of Rural Health|December 10, 2025
Emergency Department Fascia Iliaca Block Catheters: A Safe and Feasible Pathway to Hip Fracture AnalgesiaRuth Miriam Blank, Sebastiaan Paul Blank, Phuong Markman, et al.
American Journal of Hematology|October 29, 2010
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutationsHarshabad Singh, Lillian Werner, Daniel Deangelo, et al.
Oncotarget|January 5, 2018
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibitionEllen L Weisberg, Martin Sattler, Abdel Kareem Azab, et al.
Oncotarget|June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemiaAshujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemiaMitch Raponi, Jean-Luc Harousseau, Jeffrey E Lancet, et al.
Blood|November 15, 2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionCatia Fonseca, Robert Soiffer, Vincent Ho, et al.
Blood|November 28, 2013
MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cellsSuiyang Liu, Li Yin, Dina Stroopinsky, et al.
Leukemia & Lymphoma|October 15, 2016
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemiaJohn F Seymour, Hartmut Döhner, Mark D Minden, et al.
Bioengineering & Translational Medicine|September 11, 2023
Quatramer™ encapsulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancerSachchidanand Tiwari, Suiyang Liu, Mohd Anees, et al.
Emergency Medicine Australasia : EMA|October 13, 2021
Recent amendments to Queensland legislation make mental health presentations to hospital emergency departments more difficult to scrutiniseAlan R Clough, Angela Evans, Kristy Grant, et al.
Pageof 55